John G. Flannery

Affiliations: 
University of California, Berkeley, Berkeley, CA, United States 
Area:
Neuroscience , retina
Google:
"John Flannery"
Mean distance: 14.55 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Stefanov A, Flannery JG. (2022) A Systematic Review of Optogenetic Vision Restoration: History, Challenges, and New Inventions from Bench to Bedside. Cold Spring Harbor Perspectives in Medicine
Leroy BP, Fischer MD, Flannery JG, et al. (2022) Gene therapy for inherited retinal disease: long-term durability of effect. Ophthalmic Research
Berry MH, Holt A, Broichhagen J, et al. (2022) Photopharmacology for vision restoration. Current Opinion in Pharmacology. 65: 102259
McClements ME, Staurenghi F, Visel M, et al. (2022) AAV Induced Expression of Human Rod and Cone Opsin in Bipolar Cells of a Mouse Model of Retinal Degeneration. Biomed Research International. 2021: 1-8
Miyadera K, Santana E, Roszak K, et al. (2022) Targeting ON-bipolar cells by AAV gene therapy stably reverses -congenital stationary night blindness. Proceedings of the National Academy of Sciences of the United States of America. 119: e2117038119
Öztürk BE, Johnson ME, Kleyman M, et al. (2021) scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution. Elife. 10
Zin EA, Han D, Tran J, et al. (2021) Outcomes of progranulin gene therapy in the retina are dependent on time and route of delivery. Molecular Therapy. Methods & Clinical Development. 22: 40-51
Thompson DA, Iannaccone A, Ali RR, et al. (2020) Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium. Translational Vision Science & Technology. 9: 2
Byrne LC, Day TP, Visel M, et al. (2020) In vivo directed evolution of AAV in the primate retina. Jci Insight
Berry MH, Holt A, Salari A, et al. (2019) Restoration of high-sensitivity and adapting vision with a cone opsin. Nature Communications. 10: 1221
See more...